Brookstone Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
CCA
Brookstone Capital Management's RGEN Position: Q2 2021 in Review
Brookstone Capital Management sold out of Repligen (RGEN) in Q2 2021, closing a stake of 1,854 shares — an estimated $360K sold.
Brookstone Capital Management first reported a position in RGEN in Q4 2020 and held it in 2 quarters. The position peaked at $688K in Q4 2020. 428 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.
- Brookstone Capital Management reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
- Brookstone Capital Management sold 1,854 Repligen shares in Q2 2021, an estimated $360K.
- Brookstone Capital Management first reported a position in Repligen in Q4 2020 and held it in 2 quarters.
- Brookstone Capital Management's Repligen position peaked at $688K in Q4 2020.
- 428 funds tracked by Wall St. Rank held Repligen as of Q2 2021.
Based on Brookstone Capital Management's 13F filing for Q2 2021, filed 14 Jul 2021.